Every batch is third-party tested for identity, potency, sterility, and endotoxin before release
Nicolini, G., Forini, F., Kusmic, C., Iervasi, G
Severe allergic reactions Rare but possible
A reduction in the cost would shift the balance of this cost effectiveness, potentially paving the way for their longer-term use especially when coupled with research showing the reversal of weight loss after patient stop taking them, and the continued benefit in cardiovascular risk associated with longer term use. Dr Ivan Koychev of the University of Oxford, who is researching the application of GLP-1 analogues in dementia patients, said demand for such drugs was currently outstripping supply as a result of the high prevalence of obesity and type 2 diabetes